Showing results (11-20 of 198) with videos related to
Sort By:
Pageof 20
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|January 1, 1996
The impact of peritoneal permeability and residual renal function on PD prescriptionJ Harty, R GokalPeritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|January 1, 1997
Icodextrin: overview of clinical experienceE Peers, R GokalPeritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|July 16, 1999
Neuropathy and quality of life in diabetic continuous ambulatory peritoneal dialysis patientsT Apostolou, R GokalAdvances in Peritoneal Dialysis. Conference on Peritoneal Dialysis|January 1, 1989
A collection of problems in CAPDR Gokal, L UttleyNephron|January 1, 1993
Simultaneous occurrence of IgA nephropathy and sarcoidosis in the context of pre-existent minimal change nephrotic syndromeN Anwar, R GokalPostgraduate Medical Journal|December 1, 1977
The syndrome of inappropriate antidiuretic hormone secretion associated with acute myocardial infarctionG Hart, R GokalPeritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|January 1, 1996
Optimal use of glucose polymer (icodextrin) in peritoneal dialysisC D Mistry, R GokalAdvances in Peritoneal Dialysis. Conference on Peritoneal Dialysis|January 1, 1993
Vitamin D therapy in CAPD: what is its role?A J Hutchison, R GokalNephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 1, 1993
Single daily overnight (12-h dwell) use of 7.5% glucose polymer (Mw 18700; Mn 7300) +0.35% glucose solution: a 3-month studyC D Mistry, R GokalPageof 20